Buyer Takeaway: HumeCare+ is a subscription that bundles clinical GLP-1 treatment with a hardware-based tracking device - evaluate it as both a medical service and a monthly financial commitment, not just as a weight-loss product
DPP-IV, Dipeptidyl Peptidase IV
Also in the pipeline is retatrutide , a triple agonist that activates GLP-1, GIP, and glucagon receptors
Immune cells get activated, and excessive glutamate activity may lead to symptoms like motor planning impairment and sensory issues
Key points: Wegovy is a weekly injection approved for people with a BMI over 30, or 27+ with weight-related conditions It works by reducing hunger and slowing digestion Clinical trials show 15-17% weight loss after 68 weeks Its different from Mounjaro, which works on two hormone receptors instead of one Why take Wegovy if you have hypothyroidism
Tracking is available through email and the patient portal, though the in-portal tracking froze on my order and never updated